From 2026, Hungarian legislation will allow access to health-related data stored in its National eHealth Infrastructure (EESZT) for AI development on a case-by-case basis.…
- UAE Enacts New Pharma Law to Boost Pharmaceutical Innovation
- âWhat can we learn from 2024âs biotech IPOs?â â Adam Farlow chats to Fierce Biotech
- âFailure to prevent fraudâ: Baker McKenzie breakfast briefing (15 January 2025)
- The French Political Crisis Leads the Pharmaceutical and Medical Device Industries Towards A Leap Into the Unknown for 2025
- Extended Producer Responsibility for Pharmaceutical and Cosmetics Companies: Adoption of the Recast Urban Wastewater Treatment Directive
- AI Developers to Access Hungarian Health Data by 2026
- EHDS Deep-Dive: EHR systems, wellness apps and medical devices (Part 4)
- ECJ Ruling: Pharma Payments to State Health Insurers Are Rebates, Not Taxes
After months in the pipeline, it looks like the European Health Data Space (EHDS) is finally entering into force later this year. But what…
ECJ Ruling: Pharma Payments to State Health Insurers Are Rebates, Not Taxes
Pharmaceutical companies can breathe a sigh of relief following the European Court of Justiceâs recent ruling in the Novo Nordisk A/S case (C-248/23 ).…
Today the European Commission has finally published its Proposal to revise the EU Pharmaceutical legislation, the most momentous…
On 26 April 2023 the European Commission published its Proposals to Reform the EU pharmaceutical legislation.[1] We continue…
In brief Reimbursing medicinal products is critical to ensure that treatments are widely available to patients. This is…
The Proposal to revise the EU Pharmaceutical legislation has generated unprecedented levels of attention, not only across the…
As previously covered in this blog, on 26 April 2023 the European Commission published a set of proposals…
As already well noted on this blog, on 26 April 2023 the European Commission published a set of…